Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Disruptive Pharma ABOSTO:DPHA +0.83%4 Market Cap is kr53.95 Mil as of Sep. 22, 2026. GuruFocus rates OSTO:DPHA with a GF Score™ of 4/100. Among 1,022 Drug Manufacturers companies, Disruptive Pharma AB ranks worse than 89.53% on this metric.
Disruptive Pharma AB's quarterly market cap
stayed the same
from Dec. 2025 (kr29.65 Mil) to Mar. 2026 (kr29.65 Mil) but then
increased
from Mar. 2026 (kr29.65 Mil) to Jun. 2026 (kr32.27 Mil).
Disruptive Pharma AB's annual market cap
declined
from Dec. 2023 (kr360.21 Mil) to Dec. 2024 (kr237.29 Mil) and
declined
from Dec. 2024 (kr237.29 Mil) to Dec. 2025 (kr29.65 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Disruptive Pharma AB's Enterprise Value for Today is kr49.87 Mil.
Disruptive Pharma AB (OSTO:DPHA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Disruptive Pharma AB Market Cap Related Terms
Disruptive Pharma AB Market Cap Historical Data
* Premium members only.
The historical data trend for Disruptive Pharma AB's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Disruptive Pharma AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Disruptive Pharma AB Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Disruptive Pharma AB's Market Cap distribution charts can be found below:
* The bar in red indicates where Disruptive Pharma AB's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Disruptive Pharma AB's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Disruptive Pharma AB (OSTO:DPHA) has a Market Cap of kr53.95 Mil as of Sep. 22, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Disruptive Pharma AB and its competitors. According to the industry distribution chart, Disruptive Pharma AB ranks #915 out of 1022 companies in the Drug Manufacturers industry, placing it in the top 89.5%.
Is Disruptive Pharma AB's Market Cap too high?
Disruptive Pharma AB's current Market Cap is kr53.95 Mil. Based on the distribution chart, Disruptive Pharma AB ranks #915 out of 1022 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Disruptive Pharma AB has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Disruptive Pharma AB's Market Cap compare to ?
According to the Drug Manufacturers industry distribution chart, Disruptive Pharma AB ranks #915 out of 1022 companies for Market Cap. This places Disruptive Pharma AB in the lower half of its industry. The industry median Market Cap is 232.61. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 232.61, based on 1,022 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Disruptive Pharma AB and its competitors. For the Drug Manufacturers industry, the median Market Cap is 232.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Disruptive Pharma AB's current Market Cap is kr53.95 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Disruptive Pharma AB stock overvalued right now?
Disruptive Pharma AB (OSTO:DPHA) has a current Market Cap of kr53.95 Mil. The current Market Cap is kr53.95 Mil. Disruptive Pharma AB's overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Disruptive Pharma AB (OSTO:DPHA), the current Market Cap is kr53.95 Mil as of Sep. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Disruptive Pharma AB is a Swedish drug delivery technology company developing and commercializing Formulite, a patented platform based on mesoporous magnesium carbonate (MMC). The platform is designed to improve the solubility, oral bioavailability and other properties of pharmaceutical compounds. The company's business model is based on contract development, partnerships and licensing arrangements with pharmaceutical and biotechnology companies for the development and commercialization of drug products optimized with Formulite.
4GF Score
Get the complete analysis for OSTO:DPHA
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:DPHA has been successfully added to your 
